Inhibition of histamine-induced skin wheal and flare after 5 days of mizolastine

Journal of Clinical Pharmacology

Volumn 36, Issue 1, 1996, Pages 72-78

  Pinquier, Jean Louis ^a   Caplain, Henri ^b   Cabanis, Marie Josée ^a   Dubruc, Catherine ^a   Stalla Bourdillon, Aline ^a   Rosenzweig, Pierre ^a  

^a SANOFI   (France)

^b Aster   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; CETIRIZINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; LORATADINE; MIZOLASTINE; PLACEBO; TERFENADINE;

ALLERGIC RHINITIS; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; HUMAN; INTRADERMAL DRUG ADMINISTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SKIN ALLERGY; SOMNOLENCE; URTICARIA;

EID: 0030039376     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04154.x     Document Type: Article

References (18)

1. 1-receptor antagonist properties (abstract). Eur J Pharmacol 1990;183:222.
2. Danjou P, Molinier P, Berlin I, Patat A, Rosenzweig P, Morselli PL: Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects. Br J Clin Pharmacol 1992;34: 328-331.
3. Lloyd KG, Lévrier J, Duval D, Prouteau M, Berry C, Scatton B: Anti-anaphylactic activity of non sedative histamine H1-receptor antagonist SL 85.0324 in rat and guinea pig (abstract). Eur J Pharmacol 1990;183:218.
4. Lévrier J, Duval D, Pruteau M, Voltz C, Berry C, Lloyd KG, Scatton B: Antianaphylactic activity of the novel selective histamine H1-receptor antagonist mizolastine in the rodent. Arzneim Forsch Drug Res 1995;45:559-568.
5. Vuurman P, Rosenzweig P, O'Hanlon JF: Mizolastine's effects on psychomotor and actual driving performance in healthy volunteers after single 5, 10, 20 and 40 mg doses vs. clemastine 2 mg and placebo (abstract). Eur J Allerg Clin Immunol 1993;48(Suppl 16):30.
6. Kerr JS, Dunmore C, Hindmarch I: The psychomotor and cognitive effects of a new antihistamine, mizolastine, compared to terfenadine, tripolidine and placebo in healthy volunteers. Eur J Clin Pharmacol 1994;47:331-335.
7. 1-antagonist SL 85.0324 vs placebo and dimetinden in volunteers (abstract). Eur J Pharmacol 1990; 183: 593.
8. Patat A, Gram LF, Dubruc C, Brohier S, Cabanis MJ, Rosenzweig P: Effects of mizolastine, a new antihistamine, on psychomo-tor performance and memory in elderly subjects. Int Clin Psychopharmacol 1994; 9:101-108.
9. Simons FER, McMilan JL, Simons KJ: A double-blind, single-dose, cross-over comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allerg Clin Immunol 1990;86:540-547.
10. Rosenzweig P, Thébault JJ, Caplain H, Dubruc C, Bianchetti G, Fuseau E, Morselli PL: Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new non sedative H1 antihistamine. Ann Allerg 1992;69:135-139.
11. Rosenzweig P, Guillaume M, Brohier S, Ulliac N, Cabanis MJ, Thébault JJ: Comparative wheal and flare study of mizolastine versus terfenadine, cetirizine, loratadine and placebo in healthy volunters. Br J Clin Pharmacol 1995;40:459-465.
12. 2 blockade on cutaneous histamine response in man. J Allerg Clin Immunol 1980;65:136-139.
13. Ascalone V, Guinebault P, Rouchouse A: Determination of mizolastine, a new antihistaminic drug, in human plasma by liquid-liquid extraction, solid-phase extraction, and column-switching techniques in combination with high-performance liquid chromatography. J Chromatogr 1993;619:275-284.
14. Pinquier JL, Michel L, Cabanis MJ, Dubruc C, Ulliac N, Rosenzweig P, Dubertret L: Effect of mizolastine on experimental inflammation in human skin (abstract). Clin Pharmacol Ther 1995;57:169.
15. 1 inhibiting effect of cetirizine 2 HCL and loratadine. Ann Allerg 1990;65: 139-142.
16. Huther KJ, Renftle G, Barraud N, Burke JT, Koch-Weser J: Inhibitory activity of terfenadine on histamine-induced skin wheals in man. Eur J Clin Pharmacol 1977;12:195-199.
17. 1-receptor antagonists: clinical pharmacology and therapeutics. J Allerg Clin Immunol 1989;84:845-861.
18. Kontou-Fili K, Paleologos G, Herakleous M: Suppression of histamine-induced skin reactions by loratadine and cetirizine diHCL. Eur J Clin Pharmacol 1989;36:617-619.